Possible pediatric nephrotoxicity of cisplatin

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-001
• By: ABDELRAHMAN, Sarah (Children's Cancer Hospital Egypt, Department of Pharmaceutical Services & Sciences)
• Co-author(s): Sarah Mohamed Abdelrahman
  Sarah Salah
  Mahmoud Hamza
  Hala Zaki: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
  Alaa Al Haddad: Department of Pediatric Oncology & Stem Cell Transplant, Children's Cancer Hospital , Cairo, Egypt
  Helmy Moawad: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
  
• Abstract:

  Background

  Risk of Cisplatin (CDDP) nephrotoxicity, increases with increased cumulative dose, bolus dosage and associated nephrotoxic drugs. Early detection & management improves patient care.

  Methods

  51 patients scheduled to receive CDDP-based chemotherapy were recruited and scored for nephrotoxic events throughout chemotherapy course, then
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login